This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Researchers at the University of Adelaide have found that the initial stages of embryo development significantly influence an ...

Researchers from the University of Adelaide have discovered that the earliest days of embryo development have a measurable ...

Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showing that its telomere-elongating drug, Telomir-1, reduced tumor size by app ...

Researchers at the University of Adelaide found that early embryo development affects telomere length, a key marker of aging ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

New research reveals that the earliest days of embryo development have a measurable impact on a person’s future health and ...

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO ...

This part of our chromosomes can influence the ageing process, and possibly the development of chronic diseases.

DNA segments that can move from one part of the genome to another – are key to bacterial evolution and the development of ...